MPS Powered by Eureka

Clinical Cancer Drugs

ISSN: 2212-697X (Print)
eISSN: 2212-6988 (Online)

Clinical Cancer Drugs publishes original research, expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research. The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading for clinical oncologists, toxicologists, medicinal chemists, and pharmacologists.